CodeMap® 

11/18/2021 2020 Part B Utilization Data Loaded
150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2022
2021

Physician Fee Schedule

2022
2021

OPPS Fee Schedule

2022-January
2021-October

ASC Fee Schedule

2022-January
2021-October

APC Codes

2022-January
2021-October

DRG Codes

2022
2021

ASP Drug Pricing Files

January 2022
October 2021


CMS Transmittals



Shipping update: 2022 CodeMap Manuals beginning shipping 1/19. All orders will be shipped by January 31.


CodeMap® Compliance Briefing: 6/18/2010


Editor's Welcome:

Increased emphasis on chronic pain management has resulted in a dramatic increase in both drug screening and quantification as a tool in managing patients receiving pain medications. We discussed new HCPCS codes and guidance for qualitative drug screening codes in our January 22, 2010 Compliance Briefing. Today we will discuss the proper use of quantitative drug codes for reporting drug tests used to monitor and maintain appropriate therapeutic drug levels, and ensure patients are complying with recommended drug therapy. As always, please send us your comments, suggestions, and /or questions via email.

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap┬« is a Registered Trademark of Wheaton Partners, LLC.